Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TERIPARATIDE
- Teriparatide on Maxillary Sinus Floor Osseointegration
- Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
- Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture
- Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
- Romosozumab/Denosumab Study for Premenopausal IOP
- Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
- Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging
- Fracture Recovery for Returning to Duty (Teriparatide STRONG)
- Fracture Recovery for Returning to Duty (Teriparatide STRONG)
- Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture
- Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
- Abaloparatide and Pelvic Fracture Healing
- Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial
- Study of Teriparatide in Stress Fracture Healing
- Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
- A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
- Novel Combination Therapy for Osteoporosis in Men
- Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
- Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
- Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
- Comparative Antiresorptive Efficacy Discontinuation of Denosumab
- MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
- Bisphosphonates for Prevention of Post-Denosumab Bone Loss
- Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus
- The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA
- Teriparatide as a Chondroregenerative Therapy in OA
- A Comparison of PF708 and Forteo in Osteoporosis Patients
- PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
- Ankle Fractures Treated With Teriparatide
- Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
- A Comparison Study of PF708 and Forteo in Healthy Subjects
- A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
- PTH and Vibration in OSteoporosis Study
- Effects of Denosumab Therapy for Japanese
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
- Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
- Renal Osteodystrophy: An Individual Management Approach
- The Forteo Alendronate Comparator Trial
- Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics
- A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
- A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects
- Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
- Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
- Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
- A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
- The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
- Teriparatide for Fracture Repair in Humans
- Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?
- Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
- 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
- Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot
- Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
- A Phase I Study of AK159 in Healthy Postmenopausal Women
- Nasally and sc Administered Teriparatide in Healthy Volunteers
- A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)
- An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
- Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
- Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
- Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
- Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo
- VERtebral Fracture Treatment Comparisons in Osteoporotic Women
- Fracture (FX) Improvement With Teriparatide: FiX-IT Study
- The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
- Stem Cell Recruitment in Osteoporosis Therapy
- Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
- Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass
- Clinical Study of AK159 in Healthy Postmenopausal Women
- Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
- Second Study of the Effect of Teriparatide on Hip Fracture Healing
- Effect of Teriparatide on Hip Fracture Healing
- Treatment With PTH After Sternotomy in Cardiac Surgery Patients
- Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
- A Study of Teriparatide in Japanese Osteoporosis Patients
- Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial
- Teriparatide Treatment in Patients With Inherited Osteoporosis
- Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
- Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur
- Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
- The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone
- A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
- Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women
- The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures
- Teriparatide for Postsurgical Hypoparathyroidism
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
- Teriparatide (PTH) and Bone Strength in Postmenopausal Women
- Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
- µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis
- Does Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?
- Study of FORTEO Use in Subjects in the Community Setting
- Teriparatide for Improved Knee Prosthesis Fixation
- A Study for the Transdermal Application of Teriparatide
- Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
- Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
- A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
- Comparison Study of PTHrP and PTH to Treat Osteoporosis
- Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
- Back Pain in Patients With Severe Osteoporosis
- The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
- Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
- Effect of PTH(1-34) Treatment on Fracture Healing in Vivo
- Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
- A Study for Teriparatide in Severe Osteoporosis
- Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
- Cyclic Versus Daily Teriparatide on Bone Mass
- Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD
- Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
- Use of Teriparatide to Accelerate Fracture Healing
- Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy
- A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
- PTH Comparison in Post Menopausal Women
- A Study of the Treatment of Postmenopausal Women With Osteoporosis
- Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
- Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
- Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
- Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
- Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
- Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis
- Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
- Bone Properties in Hypoparathyroidism: Effects of PTH
- A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
- The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density
- Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
- Phase 3 Clinical Trial of Teriparatide in Japan
- Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
- A Study for Patients With Osteoporosis
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
- The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL
- Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
- Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
- Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
- Bone Effects of Teriparatide Following Alendronate
- Clinical Trial of Teriparatide in Japan
- Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
- Teriparatide Use in Hip Replaced Subjects
- Effects of Teriparatide on Distal Radius Fracture Healing
- Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
- OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
- Effects of Teriparatide in Postmenopausal Women With Osteoporosis
- Adding Phosphorus to Osteoporosis Drug Treatment
- Once Weekly Parathyroid Hormone for Osteoporosis
- Vitamin K and Bone Turnover in Postmenopausal Women
- Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
- Alendronate and/or Parathyroid Hormone for Osteoporosis
Clinical trials list
click for details